VRAY 0.03 Stock Price ViewRay, Inc.
Range: | 0.025-4.96 | Vol Avg: | 13063203 | Last Div: | 0 | Changes: | -0.02 |
Beta: | 0.7 | Cap: | 0.00B | Currency: | USD | Exchange: | NASDAQ |
Sector: | Healthcare | IPO: | Mon Aug 10 2015 | Empoloyees: | 295 |
CUSIP: | 92672L107 | CIK: | 0001597313 | ISIN: | US92672L1070 | Country: | US |
CEO: | Mr. Paul Ziegler Jr., J.D. | Website: | https://www.viewray.com |
ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin toxicity, and other concerns. The company serves university research and teaching hospitals, community hospitals, private practices, government institutions, and freestanding cancer centers. ViewRay, Inc. markets its MRIdian through a direct sales force and distribution network. The company was founded in 2004 and is headquartered in Oakwood, Ohio.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.